Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Mallinckrodt
Cipla
Federal Trade Commission
Boehringer Ingelheim
Express Scripts
Merck
Fish and Richardson
QuintilesIMS

Generated: May 24, 2018

DrugPatentWatch Database Preview

MYCIFRADIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Mycifradin patents expire, and what generic alternatives are available?

Mycifradin is a drug marketed by Pharmacia And Upjohn and is included in two NDAs.

The generic ingredient in MYCIFRADIN is neomycin sulfate. There are nineteen drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the neomycin sulfate profile page.
Summary for MYCIFRADIN
Drug patent expirations by year for MYCIFRADIN
Medical Subject Heading (MeSH) Categories for MYCIFRADIN
Synonyms for MYCIFRADIN
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside
(1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside sulfate
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]o
(2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-4-{[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohe
(2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3
11013-50-6
11025-81-3
119-04-0
1393-86-8
1404-04-2
1404-04-2 (acid)
1405-10-3
1405-10-3 (sulfate (salt))
25389-98-4
28002-70-2
30384-EP2272825A2
30384-EP2272838A1
30384-EP2277898A2
30384-EP2287165A2
30384-EP2287166A2
30384-EP2292620A2
30384-EP2295401A2
30384-EP2295402A2
30384-EP2298776A1
30384-EP2305662A1
30384-EP2305695A2
30384-EP2305696A2
30384-EP2305697A2
30384-EP2305698A2
30384-EP2311464A1
4-18-00-07476 (Beilstein Handbook Reference)
405N103
4BOC774388
5-amino-2-(aminomethyl)-6-[4,6-diamino-2-[4-[3-amino-6-(amin
6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyc
6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyclohexyloxy)(3S,2R,4R,5R,6
AB00443887
AB00443887-03
AC1L1QVH
AC1L52ZW
Actilin
Actiline
AKOS016340327
AKOS024284361
AN-49153
AN-5730
Antibiotic 10676
Antibiotic produced by Streptomyces decaris. Neomycin B
Antibiotique
BDBM19
BDG-(1-4)CYY-(5-1)RIB-(3-1)IDG
BDG-(1-4)NEB-(5-1)RIB-(3-1)NED
BPBio1_000326
BRD-K71013094-065-01-2
BRN 0101621
BSPBio_000296
Bycomycin
C01737
C23H46N6O13
C25H50N6O13
Caswell No. 595
CCG-220158
CCRIS 5462
CHEBI:53636
CHEBI:7508
CHEMBL1275977
CHEMBL184618
CS-6390
D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy
D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-
D-Streptamine, O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-O-beta-D-ribofuranosyl-(1-5)-O-(2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxy-, sulfate (salt)
D05140
D05JNI
D07994
D0RD0N
DB00452
DR003381
DTXSID2023359
EBD2197441
EINECS 204-292-2
EINECS 215-766-3
EINECS 248-770-9
Endomixin
Enterfram
EPA Pesticide Chemical Code 006303
F0649
Fradiomycin
Fradiomycin B
Fradiomycin sulfate
Fradiomycinum
Framicetina
Framicetina [INN-Spanish]
Framycetin
Framycetin (INN)
Framycetin [INN:BAN:DCF]
Framycetin sulfate
Framycetin sulphate
Framycetine
Framycetine [INN-French]
Framycetinum
Framycetinum [INN-Latin]
Framycin sulfate
Framygen
Fraquinol
GTPL709
HMS2089P15
HMS2095O18
HSDB 3242
HY-17624
Isofra (TN)
J-004060
Jernadex
KB-276662
KDR Kinase Inhibitor, 3
KS-1358
lohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H-3,4,5,6-tetrahydropyran-3,4-diol
LS-147029
LS-96091
LS-96095
MFCD00150827
MolPort-003-938-736
MolPort-006-108-008
Myacine
Myacyne
Mycifradin (TN)
Myciguent
NCGC00179612-01
Neo-Fradin
Neo-fradin (TN)
Neo-Rx
Neo-Tab (TN)
Neobiotic
Neobrettin
Neolate
Neomas
Neomcin
Neomicina
Neomicina [DCIT]
Neomin
neomycin
Neomycin [INN:BAN]
NEOMYCIN AND POLYMYXIN B SULFATES
NEOMYCIN B
Neomycin B sulfate
Neomycin B sulfate (salt)
Neomycin B sulphate
Neomycin B, sulfate (salt)
Neomycin solution
NEOMYCIN SULFATE
Neomycin Sulfate hydrate
Neomycin sulfate, USP grade
Neomycin sulphate
Neomycin sulphate, Antibiotic for Culture Media Use Only
Neomycin Trisulfate Hydrate
Neomycin trisulfate salt hydrate
Neomycine
Neomycine [INN-French]
Neomycinum
Neomycinum [INN-Latin]
Nivemycin
NMY
OIXVKQDWLFHVGR-WQDIDPJDSA-N
PGBHMTALBVVCIT-VCIWKGPPSA-N
PIMAVECORT
Prestwick3_000158
Q-201458
SC-83646
SCHEMBL3279
SCHEMBL373681
Sofra-Tulle (TN)
Soframycin
Soframycin (TN)
Soframycin Ophthalmic
Soframycine
ST075177
ST2419747
tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol
Tuttomycin
UNII-4BOC774388
UNII-I16QD7X297 component PGBHMTALBVVCIT-VCIWKGPPSA-N
USAF CB-19
VONAMYCIN
Vonamycin powder V
ZINC71928291

US Patents and Regulatory Information for MYCIFRADIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn MYCIFRADIN neomycin sulfate SOLUTION;ORAL 050285-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Pharmacia And Upjohn MYCIFRADIN neomycin sulfate TABLET;ORAL 060520-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
US Army
Covington
Teva
Moodys
Cerilliant
Medtronic
Julphar
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.